JILL BUYON, MD | GUEST SPEAKER

BRAD H. ROVIN, M.D.Dr. Buyon is Professor of Medicine and Director of the Division of Rheumatology  at New York University School of Medicine; Director of the NYU Lupus Center, is internationally recognized as a researcher and clinician specializing in the treatment of systemic lupus erythematosus, neonatal lupus, and rheumatic diseases in pregnancy.

She has published more than 200 papers in peer-reviewed science journals, co-authored a book on autoimmune diseases in women written for a lay audience, and was editor of the 5th edition of the comprehensive reference textbook “Systemic Lupus Erythematosus.”  She led the first multicenter study in SLE which resulted in a paradigm change with regard to the safety of contraceptive estrogens. 

Dr. Buyon received her medical degree from the Albert Einstein College of Medicine, New York, NY.  She pursued postgraduate training at the Bronx Municipal Hospital Center, New York University Medical Center, and the Hospital for Joint Diseases (HJD).  As a postdoctoral fellow at HJD in 1985, Dr. Buyon founded the HJD Lupus Clinic, and has served as its Director to this day. 

Dr. Buyon's honors include Alpha Omega Alpha and the Fabian Award for Excellence in Research.  She also received a Kirkland Scholar Award, a Distinguished Clinical Investigator Award from the American College of Rheumatology, and the Evelyn V Hess Lifetime Achievement Award for Research in Lupus from the Lupus Foundation of America.  Dr. Buyon is a fellow of the American College of Rheumatology and is responsible for the annual organization of the Lupus Study Group.

In 2008, Dr. Buyon was recognized for her bench science contribution to the pathogenesis of heart block and was elected to the American Academy of Physicians.  She has served on the Medical Advisory Board of the Lupus Foundation of America, the Biomedical Research Science Grants Committee of the Arthritis Foundation, numerous NIH Grant Review Panels, review committees for the Alliance for Lupus Research and the Lupus Research Institute, and an FDA advisory committee. 

Dr. Buyon is Principal Investigator of two ongoing NIH-funded research projects; the clinical trial “Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH)” and the basic science study, "Maternal Autoantibodies — Pathogenesis of Neonatal Lupus."  She also continues to operate the national Research Registry for Neonatal Lupus, which she founded in 1994 and which has generated the bulk of evidence-based information on this disease.  Dr. Buyon also oversees a number of industry-sponsored clinical trials of new pharmaceutical treatments for lupus. In keeping with the importance of strong translational bench to bedside leadership, Dr. Buyon approaches the study of SLE with continuous NIH funding, expertise in clinical trials and repositories, paradigm changes in managing the reproductive health of SLE women, and proven excellence in mentorship.